Shahzad Muhammad, Ashraf Mohammad, Muquit Samiul
Department of Neurosurgery, Southwest Neurosurgery Centre, University Hospitals Plymouth National Health Service (NHS) Trust, Plymouth, United Kingdom.
Wolfson School of Medicine, University of Glasgow, Scotland, United Kingdom.
Surg Neurol Int. 2025 Jan 31;16:24. doi: 10.25259/SNI_833_2024. eCollection 2025.
Spontaneous intracranial hypotension (SIH) is a rare but important condition characterized by cerebrospinal fluid (CSF) leakage, typically presenting with postural headaches. In severe cases, SIH can result in subdural hematomas (SDHs), brain herniation, and acute infarcts. The 2023 SIH guidelines recommend starting with nontargeted epidural blood patches as the initial treatment, with up to two attempts before considering a targeted patch. Nontargeted patches are effective in most cases by distributing blood widely in the epidural space. However, in rapidly deteriorating patients, targeted blood patches may be necessary, especially when a specific leak site has been identified. This report highlights the importance of timely, targeted interventions in severe SIH cases.
A 34-year-old male presented with a 6-month history of worsening headaches, impaired mobility, and stupor. On admission, his Glasgow Coma Scale was 12, which rapidly deteriorated to 5. Imaging revealed bilateral chronic SDHs, cerebellar tonsillar herniation, and signs of intracranial hypotension despite no history of trauma or anticoagulant use. Initial surgical evacuation of the hematomas failed to improve the patient's neurological status. Subsequent magnetic resonance imaging and computed tomography myelogram identified a CSF leak at the T12 level. Given the patient's critical state and rapid neurological decline, we opted for a targeted epidural blood patch at the L1/2 level. This intervention led to significant clinical improvement, with follow-up imaging demonstrating a reduction in the subdural collections and resolution of the leak. The patient fully recovered and remained asymptomatic at a 6-month follow-up.
This case highlights the need for flexibility in SIH management, particularly in severe cases with acute neurological decline. While nontargeted blood patches are typically recommended, early use of a targeted patch when imaging identifies the leak can lead to faster resolution and improved outcomes. Personalized treatment strategies are essential for managing complex SIH presentations and preventing further neurological complications.
自发性颅内低压(SIH)是一种罕见但重要的病症,其特征为脑脊液(CSF)漏出,通常表现为体位性头痛。在严重情况下,SIH可导致硬膜下血肿(SDH)、脑疝和急性梗死。2023年SIH指南建议以非靶向性硬膜外血贴作为初始治疗,在考虑靶向性血贴之前最多尝试两次。非靶向性血贴通过在硬膜外间隙广泛分布血液,在大多数情况下是有效的。然而,对于病情迅速恶化的患者,可能需要进行靶向性血贴,尤其是在已确定特定漏出部位时。本报告强调了在严重SIH病例中及时进行靶向干预的重要性。
一名34岁男性,有6个月头痛加重、活动能力受损和昏迷的病史。入院时,他的格拉斯哥昏迷量表评分为12分,随后迅速降至5分。影像学检查显示双侧慢性硬膜下血肿、小脑扁桃体疝以及颅内低压迹象,尽管他没有外伤或使用抗凝剂的病史。最初对血肿进行手术清除未能改善患者的神经状态。随后的磁共振成像和计算机断层扫描脊髓造影显示在T12水平存在脑脊液漏。鉴于患者的危急状态和神经功能迅速衰退,我们选择在L1/2水平进行靶向性硬膜外血贴。这一干预措施使临床症状显著改善,后续影像学检查显示硬膜下积液减少且漏出情况得到解决。患者完全康复,在6个月的随访中无症状。
本病例突出了SIH治疗中灵活性的必要性,特别是在伴有急性神经功能衰退的严重病例中。虽然通常推荐非靶向性血贴,但当影像学检查确定漏出部位时,早期使用靶向性血贴可导致更快的恢复和更好的治疗效果。个性化治疗策略对于处理复杂的SIH表现和预防进一步的神经并发症至关重要。